糖尿病引起骨质疏松的研究现状

被引：4

作者：

征海华

雷涛

机构：

[1] 同济大学附属同济医院内分泌科

来源：

国际内分泌代谢杂志 | 2009年 / 03期

关键词：

糖尿病; 骨密度; 骨质量; 骨质疏松;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

1002 ; 100201 ;

摘要：

糖尿病引起骨质疏松已被多数学者所公认,其发病机制在基础和临床研究中均取得很大的进展。骨形成减少和骨吸收增加是导致骨量减少的基本机制,此外要考虑到如下影响因素:高胰岛素血症,糖基化终末产物在胶原纤维上的沉积,免疫异常,雌激素以及矿物质代谢紊乱,同时,糖尿病并发症以及降糖药物的使用也参与骨质疏松的发生。而对于该病的防治主要在控制血糖的基础上予以生活方式的指导,必要时加用治疗骨质疏松的药物。

引用

页码：187 / 189

共 10 条

[1] Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China [J].

Shan, Peng-Fei ;

Wu, Xian-Ping ;

Zhang, Hong ;

Cao, Xing-Zhi ;

Gu, Wei ;

Deng, Xiao-Ge ;

Gu, Chi ;

Liao, Er-Yuan .

JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (02) :190-197

[2] The effects of zoledronic acid on serum lipids in multiple myeloma patients [J].

Gozzetti, Alessandro ;

Gennari, Luigi ;

Merlotti, Daniela ;

Salvadori, Stefania ;

De Paola, Vincenzo ;

Avanzati, Annalisa ;

Franci, Beatrice ;

Marchini, Elena ;

Tozzi, Monica ;

Campagna, Maria Stella ;

Nuti, Ranuccio ;

Lauria, Francesco ;

Martini, Giuseppe .

CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (04) :258-262

[3] Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes [J].

Schwartz, Ann V. ;

Sellmeyer, Deborah E. .

EXPERT OPINION ON DRUG SAFETY, 2008, 7 (01) :69-78

[4] Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis [J].

Vestergaard, P. .

OSTEOPOROSIS INTERNATIONAL, 2007, 18 (04) :427-444

[5] Bone loss in diabetic patients with chronic kidney disease [J].

Rigalleau, V. ;

Lasseur, C. ;

Raffaitin, C. ;

Perlemoine, C. ;

Barthe, N. ;

Chauveau, P. ;

Aparicio, M. ;

Combe, C. ;

Gin, H. .

DIABETIC MEDICINE, 2007, 24 (01) :91-93

[6]

Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?[J] . Y. Z. Bagger,H. B. Rasmussen,P. Alexandersen,T. Werge,C. Christiansen,L. B. Tankó.Osteoporosis International . 2007 (4)

[7]

Osteoclasts, rheumatoid arthritis, and osteoimmunology[J] . Kojiro Sato,Hiroshi Takayanagi.Current Opinion in Rheumatology . 2006 (4)

[8]

Advanced Glycation End Products Activate a Chymase-Dependent Angiotensin II–Generating Pathway in Diabetic Complications[J] . Vijay Koka,Wansheng Wang,Xiao Ru Huang,Shokei Kim-Mitsuyama,Luan D. Truong,Hui Y. Lan.Circulation . 2006 (10)

[9] Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients [J].

Yamagishi, S ;

Nakamura, K ;

Inoue, H .

MEDICAL HYPOTHESES, 2005, 65 (06) :1013-1015

[10]

Type 2 diabetes mellitus and osteopenia: is there an association?[J] . M. Sert,T. Tetiker,S. Kirim,S. Soyupak,A. Canataro?lu,M. Ko?ak.Acta Diabetologica . 2003 (2)

← 1 →